A little over a year ago, I took the stage at Livewire Live and made a 'shocking prediction' for 2024: we would witness “the ...

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.

Discover the growing demand for specialty training in obesity treatment as new options emerge. Learn about the current state and benefits of certification ...

Medicare’s costs could balloon by the low to middle tens of billions of dollars over 10 years due to the cost of covering GLP-1 drugs for obesity.

A trainer breaks down how to perform his #1 best fat-blasting workout for women who want to get lean, strong, and toned.

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...

After voting by viewers online, Grazer won her second Fat Bear Contest on Tuesday by defeating the male behemoth that killed ...

This retrospective cohort study included 3,389 adult patients with obesity who initiated treatment with injectable ...

An Osaka Metropolitan University research team analyzed how diabetes mellitus and obesity factor into recurrence and survival ...

Medicare coverage of weight loss drugs, if authorized, is seen increasing federal spending by about $35B from 2026 to 2034.